
Thermo Fisher Scientific TMO
€ 428.84
2.39%
Geschäftsbericht 2025
hinzugefügt 26.02.2026
Thermo Fisher Scientific Kurshistorie 2011-2026 | TMO
Kurshistorie Jährlich Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 520 | 539 | 560 | 551 | 544 | 449 | 289 | 258 | 206 | 155 | 127 | 127 | 121 | 71.2 | 54.2 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 560 | 54.2 | 305 |
Kurshistorie anderer Aktien in der Diagnostik & Forschung
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
139 | $ 116.73 | 2.5 % | $ 35.5 B | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 25.1 | 1.09 % | $ 697 M | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Danaher Corporation
DHR
|
210 | $ 196.39 | 2.82 % | $ 140 B | ||
|
Exact Sciences Corporation
EXAS
|
103 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 16.2 | 1.85 % | $ 490 M | ||
|
CareDx, Inc
CDNA
|
18.6 | $ 17.93 | 1.45 % | $ 955 M | ||
|
Guardant Health
GH
|
107 | $ 94.2 | 0.96 % | $ 11.8 B | ||
|
DexCom
DXCM
|
65.4 | $ 65.33 | 3.53 % | $ 25.5 B | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Burning Rock Biotech Limited
BNR
|
8.43 | $ 15.99 | -0.62 % | $ 172 M | ||
|
Co-Diagnostics
CODX
|
4.4 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 107.95 | 0.74 % | $ 8.9 B | ||
|
Interpace Biosciences
IDXG
|
1.66 | $ 2.0 | 0.25 % | $ 8.85 M | ||
|
Illumina
ILMN
|
103 | $ 128.01 | 1.24 % | $ 20.4 B | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
IQVIA Holdings
IQV
|
165 | $ 173.83 | 1.88 % | $ 29.9 B | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
Laboratory Corporation of America Holdings
LH
|
287 | $ 275.0 | 2.17 % | $ 22.9 B | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 80.06 | 2.54 % | $ 5.4 B | ||
|
Charles River Laboratories International
CRL
|
155 | $ 175.68 | 3.62 % | $ 8.71 B | ||
|
Medpace Holdings
MEDP
|
449 | $ 521.98 | 2.65 % | $ 15.1 B | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
1.38 K | $ 1 320.64 | 3.99 % | $ 27.2 B | ||
|
Myriad Genetics
MYGN
|
4.42 | $ 4.82 | 1.58 % | $ 446 M | ||
|
NeoGenomics
NEO
|
11.6 | $ 8.27 | 2.54 % | $ 1.06 B | ||
|
Biodesix
BDSX
|
0.71 | $ 14.44 | -0.65 % | $ 1.87 B | ||
|
OpGen
OPGN
|
1.96 | - | -16.95 % | $ 1.54 M | ||
|
Natera
NTRA
|
53.9 | $ 211.74 | 1.18 % | $ 20.8 B | ||
|
Pacific Biosciences of California
PACB
|
1.66 | $ 1.47 | 2.15 % | $ 441 M | ||
|
PerkinElmer
PKI
|
115 | - | -0.91 % | $ 14.7 B | ||
|
Quotient Limited
QTNT
|
2.59 | - | -11.32 % | $ 1.1 M | ||
|
Precipio
PRPO
|
23.9 | $ 28.05 | -1.58 % | $ 45 M | ||
|
Personalis
PSNL
|
4.28 | $ 6.42 | 4.05 % | $ 380 M | ||
|
QIAGEN N.V.
QGEN
|
38.3 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
3.19 | $ 2.7 | 0.37 % | $ 87.6 K | ||
|
Biomerica
BMRA
|
3.13 | $ 2.16 | - | $ 4.96 M | ||
|
BioNano Genomics
BNGO
|
1.46 | $ 1.18 | 0.43 % | $ 6.43 M | ||
|
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M |